Tomorrow, we kick off the re-launch of the ESCMID Vaccines Conference, this time in collaboration with ESPID, EAHP and EMA. Over the next days we will be covering all areas of vaccines from development to clinical practice which you can see in the programme on our website. For those who are in Lisbon, Portugal, onsite registration is also now available at the venue.

Science and Research

We are awarding 50 young scientists with up to 2K EUR to travel to one of the over 100 collaborative centres to gain experience and exchange knowledge with colleagues in the fields of clinical microbiology and infectious diseases.

Applications are still open for the TAE Outstanding Trainee Award until 30 September 2025. This award honours early-career scientists and doctors who demonstrate exceptional skills throughout their involvement with extracurricular activities, teaching, networking, and collaboration within the fields of CM and ID. Learn more on the eligibility and monetary award on our website.

Education

Due to recent demand, we have extended the deadline for registration for the “Empowering women in leadership” course. This course organised by the ESCMID Foundation is designed specifically for women in healthcare to strengthen their leadership skills and gain practical strategies for leading diverse teams. The new deadline for registration is 10 October 2025.

Multidrug-resistant Gram-negative bacteria (MDR-GNB) remain one of the greatest challenges for hospitals. This specialised course offers professionals the knowledge and tools to recognise resistance mechanisms, track current epidemiology, and implement effective surveillance and infection control strategies.

This course is part of the ESCMID EUCIC Certificate Programme and has a few spots available for additional participants.

Congress and Events

Last chance for registration to the IMMEM conference starting next week. Taking place in Porto, Portugal this will be the 14th edition of the event, and it will cover the latest developments in microbial typing and epidemiology. See the full programme and register today!

Guidelines and Journals

ESCMID is currently seeking candidates willing to serve on the panels that will develop the next seven ESCMID clinical practice guidelines in 2026-2027. You can learn more about the projects on our website and apply to join a panel before 10 October 2025.

The draft document, “Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026” is now available for public consultation. ESCMID members wishing to participate can learn more on our website. Comments must be submitted before 01 October 2025.

In this episode of Communicable, Angela Huttner and Erin McCreary invite two titans of vaccinology, Barney Graham, former deputy director of the NIH NIAID Vaccine Research Center and architect of the mRNA vaccines against COVID-19, and Gary Kobinger, leading virologist in the development of the first effective Ebola vaccine, for a candid conversation about their direct experience building two of the most well-known vaccines to date, and deploying them to the public.

An Ebola outbreak was confirmed in DRC, with 28 suspected cases and 15 deaths; sequencing shows a new zoonotic spillover. The EU faces a multi-country Salmonella strathcona outbreak: 289 cases since 2023 in 22 countries. Chikungunya and dengue cases are reported in France (301 chikungunya / 19 dengue) and Italy (107 chikungunya / 4 dengue). Intense transmission of West Nile virus in Italy with 502 cases, including 226 neuroinvasive and a 14.6% fatality rate.

The Role of Rapid and Advanced Microbiological Methods in Critical Care: 2025 EMANUELE RUSSO Delphi Consensus

Prevalence of submicroscopic malaria parasitemia among migrant pregnant women: a prospective cohort study